These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17706161)

  • 1. Diagnosis and treatment of acute promyelocytic leukemia.
    Jurcic JG; Soignet SL; Maslak AP
    Curr Oncol Rep; 2007 Sep; 9(5):337-44. PubMed ID: 17706161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of molecular phenotypes to detect relapse and optimize the management of acute promyelocytic leukemia.
    Hasan SK; Lo-Coco F
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10 Suppl 3():S139-43. PubMed ID: 21115433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia.
    Grimwade D; Lo Coco F
    Leukemia; 2002 Oct; 16(10):1959-73. PubMed ID: 12357347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
    Chen SJ; Chen LJ; Zhou GB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute promyelocytic leukemia in children and adolescents.
    Stein EM; Tallman MS
    Acta Haematol; 2014; 132(3-4):307-12. PubMed ID: 25228556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic effects of arsenic trioxide on acute promyelocytic leukemia and other types of leukemias.
    Yousefnia S
    Cell Biol Int; 2021 Jun; 45(6):1148-1157. PubMed ID: 33527587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring PML-RARalpha in acute promyelocytic leukemia.
    Jurcic JG
    Curr Oncol Rep; 2003 Sep; 5(5):391-8. PubMed ID: 12895391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
    Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment strategies for newly diagnosed and relapsed APL].
    Emi N
    Rinsho Ketsueki; 2017; 58(10):1872-1877. PubMed ID: 28978827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute promyelocytic leukemia: state-of-the-art management].
    Asou N
    Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis.
    Chen Z; Wang ZY; Chen SJ
    Pharmacol Ther; 1997; 76(1-3):141-9. PubMed ID: 9535176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
    Tallman MS
    Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancer.
    Mi JQ; Chen SJ; Zhou GB; Yan XJ; Chen Z
    J Intern Med; 2015 Dec; 278(6):627-42. PubMed ID: 26058416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of arsenic in acute promyelocytic leukemia.
    Tallman MS
    Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.
    Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD
    Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
    Grimwade D; Mistry AR; Solomon E; Guidez F
    Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
    Leu L; Mohassel L
    Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.
    Miller WH; Kakizuka A; Frankel SR; Warrell RP; DeBlasio A; Levine K; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2694-8. PubMed ID: 1372989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.